openPR Logo
Press release

Nasal Atomizer Devices Market Growth and Restrain Factors Analysis by 2025

03-01-2018 12:14 PM CET | Health & Medicine

Press release from: Transparency Market Research

Nasal Atomizer Devices Market Growth and Restrain Factors

Nasal Atomizer Devices are used to administer drugs through the nasal mucosa. Drug delivery used for topical treatment of nasal diseases such as sinusitis and allergic rhinitis. The nasal route of administration is considered in certain cases over the conventional oral route due to the fact that rapid absorption of the drug takes place with more efficient drug administration. Therefore, it is a more desired route of administration for noninvasive vaccination and target specific drug delivery. The nasal route addresses restraints of poor drug bioavailability, slow absorption rate, drug degradation, and adverse events in the gastrointestinal tract.

Atomized nasal drugs get rapidly absorbed across the mucosal membranes and into the bloodstream by avoiding first-pass metabolism. Nevertheless, during nasal delivery, one needs to protect the lungs from hazardous exposures. Nasal atomizer devices utilize medication in liquid form which are administered through the nasal route using droppers, nebulizers spray pumps, and atomizers attached to the tip. The drug present in the atomizers travels through the tip in the form of atomized mist which helps in increasing the surface area of the drug on the nasal mucosal. Nasal atomizer devices have a number of compelling advantages over other devices. These devices are non-invasive, provide for fast execution of therapeutically relevant concentrations of drug into the bloodstream, helps by-pass metabolism of the body, and lastly these devices provide ease of administration of the drug. Accurate dosing is essential in a nasal atomization device to bypass any side effects due to overdose. Auto-disable feature in a nasal atomizer allows for increased efficiency in infection control with decreased risk of cross contamination by preventing any repeated use by one or the other patient.

Nasal atomizer devices are cone shaped, equipped with a luer-lock attachment which allows it to be connected to any standard luer-lock syringe. The nasal cone present on the device allows for comfortable and appropriate positioning of the device against the nasal opening, thus preventing chances of accidental trauma. These devices are currently being used in the treatment of allergic rhinitis and sinusitis. Nasal atomizer devices are multi-dose products allowing for long-term usage. In 2004, Kurve Technology Inc. designed and developed a nasal drug delivery device ViaNase which has a controlled particle dispersion method.

Nasal atomizer devices can be classified as gas propelled or electrical. The air or gas controlled technology involves the use of a bottle which when pressed or squeezed releases the drug content through a small nozzle tip in definite volume. The delivered drug dose is dependent on the amount of pressure applied on the bottle. An electronic atomizer on the other hand is developed to release a predefined amount of drug through the nozzle which makes it easy to use in homecare settings by individuals.

Request to View Brochure of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=32207

Major drivers of the nasal atomizer devices market are increasing prevalence of sinusitis, increasing academic & clinical research activity, increasing collaboration between organizations to increase awareness, changing lifestyle, advancements in healthcare industry, launch of novel therapeutics, increasing per capita income in emerging economies, and increasing number of regulations mandated by regulatory bodies for more efficient and cost effective drug delivery systems. For instance, the World Health Organization (WHO) has specific guidelines for manufacturers, which outlines all requirements the WHO deems essential for the adoption of a new immunization delivery system which should constitute a single-use delivery system. Increasing trends of self-medication is a lucrative opportunity for the global nasal drug delivery devices market. On the other hand, major restraints associated with the nasal atomizer devices market are pathological conditions such as cold or allergies that can affect the bioavailability of the drug during administration, rapid removal of the therapeutic agent from the site of administration is difficult, and stringent government regulations and unfavorable reimbursement rates.

Request to View ToC of Report -

https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=32207

Geographically the global nasal atomizer devices market has been divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America region leads the cancer supportive care therapeutic market globally due of increasing population, increasing patient pool, growing geriatric population, increasing number of screening procedures, presence of leading manufacturers, and technological advancements. The North America market is closely followed by Europe and Asia Pacific. The Asia Pacific region is an emerging market for cancer supportive care therapeutics mainly because of increasing healthcare expenditure in the region, increasing population and growing awareness. High rate of acceptance of new technologies in developed regions of North America and Europe is expected to maintain the dominance of these regions in the global nasal atomizer devices market.

Major players in the global nasal atomizer devices market include Becton Dickenson, Pfizer, DeVilbiss Healthcare, Teleflex Incorporated, Kurve Technology, and others.

View Report -

https://www.transparencymarketresearch.com/nasal-atomizer-devices-market.html

About Us

Transparency Market Research (TMR) is a market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants, use proprietary data sources and various tools and techniques to gather, and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

US Office Contact
90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Nasal Atomizer Devices Market Growth and Restrain Factors Analysis by 2025 here

News-ID: 962503 • Views: 120

More Releases from Transparency Market Research

Wearable EEG Devices Market: Growing incidences of Neurovascular Disorders is Dr …
According to new market research titled 'Wearable EEG Devices Market to 2027 - Global Analysis and Forecasts by Channel and Application.' The global wearable EEG devices market is expected to reach US$ 1,556.35 Mn in 2027 from US$ 745.05 Mn in 2018. The market is projected to grow with a CAGR of 8.7% from 2019-2027. The report provides trends prevailing in the global wearable EEG devices market and the factors
Decentralized Electricity Generation Market - Global Industry Analysis, Share, G …
Global Decentralized Electricity Generation Market: Overview With the increasing installation of smart grids and the rising number of electricity generation resources, the power generation industry has been undergoing a significant change over the recent past. The modification in the grid structure, which permits decentralization of electricity generation, is acting as the main driving force behind the substantial growth of the global market for decentralized electricity generation. The main objective of this research
Global Sucralose Market Outlook In The Developed And Emerging Industry
Sucralose Market Overview Sugar substitute market is witnessing an increasing demand driven by the increasing sales of various sugar substitutes such as natural sweeteners and artificial sweeteners. Sucralose, an artificial sweetener used as a sugar substitute is highly preferred by consumers owing to its zero calorie attribute. Though sucralose is 600 times sweeter than sugar but interestingly it is not identified as the carbohydrate by the human body. Sucralose has its
Flavored Syrup Market - Growth Powered with Latest Development Scenario & Influe …
Flavored Syrup Market Introduction Global syrup market is witnessing a significant demand generated by the food and beverage industry. Consumers' increasing preference for different and personalized flavors in food has driven the syrup manufacturers to produce a wide range of flavored syrups. Flavored syrups contain artificial or natural flavorings mixed along with sugar and water. Obtain Report Details @ https://www.transparencymarketresearch.com/flavored-syrup-market.html Increasing demand of flavored syrups especially among the consumers contributes to the

All 5 Releases


More Releases for Nasal

Global Nasal Cannulas Market Research Report
This report studies the global Nasal Cannulas market status and forecast, categorizes the global Nasal Cannulas market size (value & volume) by manufacturers, type, application, and region. This report focuses on the top manufacturers in North America, Europe, Japan, China, and other regions (India, Southeast Asia). The major manufacturers covered in this report Medtronic BD Salter Labs Teleflex Westmed Smiths Medical Flexicare A-M Systems Intersurgical Geographically, this report studies the
Nasal Polyps Therapeutics Pipeline Review 2018
Nasal polyps are the type of lesions that arises from the mucosa of the nasal cavity. The cause of nasal polyps is still unknown. According to researchers, chronic inflammation in the nose and nasal sinuses are responsible for the occurrence of nasal polyps. Nasal polyps can be symptomatized by the runny nose, postnasal drip, absent sense of smell, facial pain, pain in upper teeth, snoring, persistent stuffiness, and sense of
Nasal Aspirator Market
Nasal aspirator is a small medical device which is used to clear the nose of a baby. When babies suffered from cold, the snot (nasal mucus) develop in their nose. Unfortunately, babies do not know how to blow their nose to clear, nasal aspirators, however, work effectively in clearing up their stuffy nose and give them immediate relief from breathlessness. A nasal respirator is cheap and is easy to use.
Nasal Polyposis - Pipeline Review, H2 2017
ReportsWorldwide has announced the addition of a new report title Nasal Polyposis - Pipeline Review, H2 2017 to its growing collection of premium market research reports. Summary Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nasal Polyposis - Pipeline Review, H2 2017, provides an overview of the Nasal Polyposis (Ear Nose Throat Disorders) pipeline landscape. Nasal polyps (NP) are non cancerous growths within the nose or sinuses. Symptoms include runny nose,
Absorbable Nasal Implant Devices Market
Absorbable nasal implants are used to treat nasal blockage or obstructions and allow better breathing and sleep to the patient. Nasal airway obstruction can be caused by several factors, including septal deviation, enlarged turbinates, and weakened upper and/or lower lateral nasal wall cartilage, which can lead to nasal valve collapse (vestibular stenosis). Symptoms include stuffiness, congestion or an inability to breathe through one or both nostrils. The nasal valve
Nasal Polyposis - Pipeline Review, H1 2017
ReportsWorldwide has announced the addition of a new report title Nasal Polyposis - Pipeline Review, H1 2017 to its growing collection of premium market research reports. Global Markets Direct's latest Pharmaceutical and Healthcare disease pipeline guide Nasal Polyposis - Pipeline Review, H1 2017, provides an overview of the Nasal Polyposis (Ear Nose Throat Disorders) pipeline landscape. Nasal polyps (NP) are non cancerous growths within the nose or sinuses. Symptoms include runny nose,